{"schema_version":"secwatch.filing_event.v1","accession":"0001746473-25-000182","form_type":"8-K","ticker":"PLRX","cik":"0001746473","company_name":"PLIANT THERAPEUTICS, INC.","filed_at":"2025-12-16T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.329194+00:00","generated_at":"2026-05-16T13:04:43.364095+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Pliant Therapeutics promotes Minnie Kuo to COO effective December 10, 2025","bullets":["Minnie Kuo appointed Chief Operating Officer, effective immediately; previously served as Chief Development Officer since September 2023.","Ms. Kuo has over 20 years of multinational clinical development experience, including senior roles at Vir Biotechnology, Gilead Sciences, and Roche/Genentech.","No additional compensation provided with the COO appointment."],"urls":{"canonical":"https://secwatch.observer/filing/0001746473-25-000182","json":"https://secwatch.observer/filing/0001746473-25-000182.json","markdown":"https://secwatch.observer/filing/0001746473-25-000182.md","text":"https://secwatch.observer/filing/0001746473-25-000182.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1746473/000174647325000182/0001746473-25-000182-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1746473/000174647325000182/plrx-20251210.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T13:04:43.364095+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}